IFNG and multiple sclerosis: Likewise, following the treatment of DCs with IFN-γ, Dex carrying specific microRNAs increased baseline myelination, reduced oxidative stress, and improved remyelination in acute autoimmune lysolecithin-induced demyelination, which illustrates the potential of IFN-γ-Dex in the treatment of multiple sclerosis and other demyelinating syndromes [131].